We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRTS
2126
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$850K ﹤0.01%
246,326
+212,710
+633% +$607K
BSET icon
2127
Bassett Furniture
BSET
$169M
$844K ﹤0.01%
48,574
-87
-0.2% -$1.54K
HT
2128
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$844K ﹤0.01%
+99,047
New +$889K
TUR icon
2129
CALL
iShares MSCI Turkey ETF
TUR
$201M
$844K ﹤0.01%
22,800
-3,200
-12% -$97.9K
GBX icon
2130
The Greenbrier Companies
GBX
$1.57B
$843K ﹤0.01%
25,127
+3,877
+18% +$129K
SIVB
2131
DELISTED
SVB Financial Group
SIVB
$840K ﹤0.01%
+3,649
New +$906K
AUPH icon
2132
Aurinia Pharmaceuticals
AUPH
$1.95B
$839K ﹤0.01%
+194,281
New +$1.13M
NVR icon
2133
NVR
NVR
$17.1B
$835K ﹤0.01%
181
-47
-21% -$207K
BLUA.WS
2134
CALL
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$833K ﹤0.01%
83,328
VEON icon
2135
VEON
VEON
$3.5B
$833K ﹤0.01%
67,986
USMV icon
2136
iShares MSCI USA Min Vol Factor ETF
USMV
$23.6B
$829K ﹤0.01%
11,500
+7,900
+219% +$562K
LDTCW
2137
CALL
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$828K ﹤0.01%
83,328
DBX icon
2138
Dropbox
DBX
$7.78B
$828K ﹤0.01%
36,987
-112,712
-75% -$2.48M
GLOP
2139
DELISTED
GASLOG PARTNERS LP
GLOP
$827K ﹤0.01%
+124,138
New +$912K
ABBV icon
2140
PUT
AbbVie
ABBV
$465B
$824K ﹤0.01%
5,100
-3,900
-43% -$598K
HGASW
2141
CALL
DELISTED
Global Gas Corporation Warrant
HGASW
$811K ﹤0.01%
85,317
GRRRW
2142
CALL
Gorilla Technology Group Warrant
GRRRW
$1.97M
$811K ﹤0.01%
100,000
HWKZ.WS
2143
CALL
DELISTED
Hawks Acquisition Corp Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
HWKZ.WS
$809K ﹤0.01%
80,484
SCPH
2144
DELISTED
scPharmaceuticals
SCPH
$808K ﹤0.01%
+112,702
New +$689K
CGBD icon
2145
Carlyle Secured Lending
CGBD
$708M
$806K ﹤0.01%
56,354
+31,054
+123% +$415K
VLGEA icon
2146
Village Super Market
VLGEA
$657M
$803K ﹤0.01%
34,487
-7,022
-17% -$156K
CUK
2147
DELISTED
Carnival PLC
CUK
$801K ﹤0.01%
111,456
-309,439
-74% -$2.38M
SNEX icon
2148
StoneX
SNEX
$8.72B
$801K ﹤0.01%
+42,555
New +$787K
CAAP icon
2149
Corporacion America
CAAP
$4.17B
$801K ﹤0.01%
91,762
+28,441
+45% +$230K
SEMR
2150
DELISTED
Semrush
SEMR
$799K ﹤0.01%
98,183
-15,014
-13% -$152K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.